Gervasio A. Lamas

Gervasio A. Lamas's AcademicInfluence.com Rankings

Gervasio A. Lamas

Philosophy

#9311

World Rank

#12850

Historical Rank

Logic

#6293

World Rank

#7801

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Gervasio A. Lamas Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gervasio A. Lamas's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi (2004) (7144)
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction (2003) (1486)
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008) (1319)
Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. (1988) (1113)
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (927)
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. (2002) (892)
Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril (1994) (847)
Focused Update of the ACC / AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (2007) (740)
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) (2003) (694)
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. (1997) (668)
Coronary intervention for persistent occlusion after myocardial infarction. (2006) (599)
Ventricular dysfunction and the risk of stroke after myocardial infarction. (1997) (579)
Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber Pacing (1998) (562)
A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. (1982) (526)
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. (1997) (501)
Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. (2002) (424)
Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. (2007) (417)
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. (1994) (348)
Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. (1992) (292)
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. (1992) (235)
Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing: Meta-Analysis of Randomized Trials, Using Individual Patient Data (2006) (233)
Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure. (2014) (222)
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. (2013) (215)
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. (1995) (215)
Characterization of health‐related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM (2007) (213)
Stability of Time-tradeoff Utilities in Survivors of Myocardial Infarction (1993) (205)
Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. (2004) (197)
Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. (1989) (182)
Complications arising after implantation of DDD pacemakers: the MOST experience. (2003) (176)
Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. (1998) (173)
Randomized Trial of Percutaneous Coronary Intervention for Subacute Infarct-Related Coronary Artery Occlusion to Achieve Long-Term Patency and Improve Ventricular Function: The Total Occlusion Study of Canada (TOSCA)–2 Trial (2006) (165)
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. (2004) (158)
The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. (2000) (150)
Randomized Trials of Vitamin E in the Treatment and Prevention of Cardiovascular Disease (2004) (149)
Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. (1995) (141)
Outcomes of minimally invasive valve surgery versus median sternotomy in patients age 75 years or greater. (2011) (138)
Outcomes of minimally invasive valve surgery versus standard sternotomy in obese patients undergoing isolated valve surgery. (2011) (138)
Selection Bias in the Use of Thrombolytic Therapy in Acute Myocardial Infarction (1991) (133)
Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. (2004) (127)
Cost-effectiveness of captopril therapy after myocardial infarction. (1995) (122)
Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. (1998) (122)
Complications of Dual Chamber Pacemaker Implantation in the Elderly (1998) (120)
Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy. (2016) (120)
High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). (2004) (118)
Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration. (2005) (115)
Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective (2008) (101)
Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT‐HF) (2011) (100)
Functional status versus utilities in survivors of myocardial infarction. (1991) (97)
Increased left ventricular volume following myocardial infarction in man. (1986) (94)
Left ventricular thrombus formation after first anterior wall acute myocardial infarction. (1988) (94)
Impact of Collateral Flow to the Occluded Infarct-Related Artery on Clinical Outcomes in Patients With Recent Myocardial Infarction: A Report From the Randomized Occluded Artery Trial (2010) (88)
The Effect of an EDTA-based Chelation Regimen on Patients With Diabetes Mellitus and Prior Myocardial Infarction in the Trial to Assess Chelation Therapy (TACT) (2014) (88)
A randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women. (2007) (87)
Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. (2010) (85)
Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. (2004) (82)
Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). (2007) (82)
Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). (2006) (81)
Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction. (2004) (79)
The national cholesterol education program diet vs a diet lower in carbohydrates and higher in protein and monounsaturated fat: a randomized trial. (2004) (74)
Evidence Base for Pacemaker Mode Selection: From Physiology to Randomized Trials (2004) (73)
Design of the Trial to Assess Chelation Therapy (TACT). (2012) (70)
Design and methodology of the Occluded Artery Trial (OAT). (2005) (69)
Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial. (2008) (66)
The late open artery hypothesis--a decade later. (2001) (65)
Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial. (2006) (60)
Patency of the infarct-related coronary artery and ventricular geometry. (1991) (58)
Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarction. (2007) (57)
Oral High-Dose Multivitamins and Minerals After Myocardial Infarction (2013) (55)
Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction (2005) (55)
Predictors of stroke in patients paced for sick sinus syndrome. (2004) (54)
The obesity paradox in elderly obese patients undergoing coronary artery bypass surgery. (2011) (53)
Outcome and Cost-Effectiveness of Cardiopulmonary Resuscitation after In-Hospital Cardiac Arrest in Octogenarians (2002) (52)
Left ventricular remodeling after acute myocardial infarction: clinical course and beneficial effects of angiotensin-converting enzyme inhibition. (1991) (50)
Development and prevention of congestive heart failure following myocardial infarction. (1993) (49)
Does Dual Chamber or Atrial Pacing Prevent Atrial Fibrillation? The Need for a Randomized Controlled Trial (1992) (49)
The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease. (2002) (47)
Clinical characteristics of patients intolerant to VVIR pacing. (2000) (47)
Outcomes of right minithoracotomy mitral valve surgery in patients with previous sternotomy. (2011) (46)
Quality of life after late invasive therapy for occluded arteries. (2009) (46)
Cost of medical services in older patients with heart failure: those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: the Heart Failure Home Care trial. (2010) (46)
Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort. (2012) (45)
Predictors and Clinical Impact of Atrial Fibrillation After Pacemaker Implantation in Elderly Patients Treated with Dual Chamber Versus Ventricular Pacing (2003) (45)
Staged percutaneous coronary intervention and minimally invasive valve surgery: results of a hybrid approach to concomitant coronary and valvular disease. (2012) (44)
Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables. (1995) (43)
Ventricular Remodeling Does Not Accompany the Development of Heart Failure in Diabetic Patients After Myocardial Infarction (2002) (43)
Left main coronary artery acute thrombosis related to energy drink intake. (2012) (42)
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial). (2004) (41)
Impact of National Clinical Guideline recommendations for revascularization of persistently occluded infarct-related arteries on clinical practice in the United States. (2011) (41)
EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy. (2014) (41)
Role of left ventricular dysfunction in neurohumoral activation in the recovery phase of anterior wall acute myocardial infarction (1990) (41)
Clinical evaluation of chelation therapy: is there any wheat amidst the chaff? (2000) (40)
Association of Prolonged QRS Duration With Death in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction (2005) (40)
Incidence of postoperative atrial fibrillation in patients undergoing minimally invasive versus median sternotomy valve surgery. (2013) (40)
A simplified method to predict occurrence of complete heart block during acute myocardial infarction (1986) (40)
The Influence of Atrial and Ventricular Pacing on the Incidence of Atrial Fibrillation: A Meta‐Analysis (2011) (39)
Long-Term Effects of Percutaneous Coronary Intervention of the Totally Occluded Infarct-Related Artery in the Subacute Phase After Myocardial Infarction (2011) (38)
Health values before and after pacemaker implantation. (2002) (37)
Pacemaker backup-mode reversion and injury during cardiac surgery. (1986) (36)
Outcomes of minimally invasive valve surgery in patients with chronic obstructive pulmonary disease. (2012) (35)
The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone. (2011) (35)
Age‐Related Differences in Management of Heart Disease: A Study of Cardiac Medication Use in an Older Cohort (1999) (35)
A simplified method to predict occurrence of complete heart block during acute myocardial infarction. (1987) (35)
How much atrial fibrillation is too much atrial fibrillation? (2012) (34)
Outcomes of reoperative aortic valve replacement via right mini-thoracotomy versus median sternotomy. (2013) (33)
Clinical and Quality of Life Comparison of Accelerometer, Piezoelectric Crystal, and Blended Sensors in DDDR‐Paced Patients with Sinus Node Dysfunction in the Mode Selection Trial (MOST) (2005) (32)
Pacemaker mode selection and survival: a plea to apply the principles of evidence based medicine to cardiac pacing practice. (1997) (32)
Nitric oxide synthase isoform inhibition before whole body ischemia reperfusion in pigs: vital or protective? (2007) (31)
Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committee. (2006) (30)
Treatment and prevention of atrial fibrillation with nonantiarrhythmic pharmacologic therapy (2005) (30)
Ejection fraction by radionuclide ventriculography and contrast left ventriculogram. A tale of two techniques. SAVE Investigators. Survival and Ventricular Enlargement. (1999) (30)
Left ventricular geometry and operative mortality in patients undergoing mitral valve replacement (2001) (29)
Usefulness of the CHA2DS2VASc score to predict postoperative stroke in patients having cardiac surgery independent of atrial fibrillation. (2015) (29)
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial. (2004) (26)
Pacemaker Mode Selection: (2003) (26)
Outcomes of a minimally invasive approach compared with median sternotomy for the excision of benign cardiac masses. (2011) (25)
Lead and Cadmium as Cardiovascular Risk Factors: The Burden of Proof Has Been Met (2021) (25)
Electrophysiological Effects of Late Percutaneous Coronary Intervention for Infarct-Related Coronary Artery Occlusion: The Occluded Artery Trial–Electrophysiological Mechanisms (OAT-EP) (2009) (25)
Incidence of cerebrovascular accidents in patients undergoing minimally invasive valve surgery. (2014) (25)
Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemaker leads (1996) (24)
Prospective Randomized Study of Mode Switching in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction (2004) (23)
Fluoroscopic Technique of Subclavian Venous Puncture for Permanent Pacing: A Safer and Easier Approach (1988) (22)
CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation. (2015) (22)
Periodic acceleration (pGz) prior to whole body ischemia reperfusion injury provides early cardioprotective preconditioning. (2010) (21)
Age-related differences in management of heart disease: a study of cardiac medication use in an older cohort. Pacemaker Selection in the Elderly (PASE) Investigators. (1999) (21)
Pacemaker malfunction after nitrous oxide anesthesia. (1985) (21)
Beneficial effects of an open artery on left ventricular remodeling after myocardial infarction. (2000) (21)
Effect of cigar smoking on endothelium-dependent brachial artery dilation in healthy young adults. (2002) (21)
Different roles of nitric oxide synthase isoforms in cardiopulmonary resuscitation in pigs. (2007) (21)
Clinical response to coronary artery reoperations. (1986) (21)
Clinical predictors of prosthesis-patient mismatch after aortic valve replacement for aortic stenosis (2012) (21)
Reduced Ejection Fraction, Sudden Cardiac Death, and Heart Failure Death in the Mode Selection Trial (MOST): Implications for Device Selection in Elderly Patients with Sinus Node Disease (2008) (21)
Pacemaker mode selection: the evidence from randomized trials. (2003) (20)
Death in patients with permanent pacemakers for sick sinus syndrome. (2003) (20)
Cadmium level and severity of peripheral artery disease in patients with coronary artery disease (2018) (20)
Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial infarction. (1990) (19)
Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients. (2014) (19)
Is a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy? (2012) (19)
Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: rationale and design of the PREVENT-HF study. (2007) (19)
EDTA chelation therapy meets evidence-based medicine. (2006) (19)
Body image changes associated with dual-chamber pacemaker insertion in women. (2004) (18)
Hybrid approach of percutaneous coronary intervention followed by minimally invasive valve operations. (2014) (18)
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction (2002) (18)
Echocardiographic comparison of cardiopulmonary resuscitation (CPR) using periodic acceleration (pGz) versus chest compression. (2005) (18)
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular Enlargement. (1998) (18)
Outcomes of Minimally Invasive Mitral Valve Surgery in Patients with an Ejection Fraction of 35% or Less (2013) (17)
Physiological Consequences of Normal Atrioventricular Conduction: Applicability to Modern Cardiac Pacing (1989) (17)
Prognostic use of echocardiography 1 year after a myocardial infarction. (2005) (17)
Incidence of postoperative acute kidney injury in patients with chronic kidney disease undergoing minimally invasive valve surgery. (2013) (17)
The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT). (2019) (17)
Medical Therapy for Calcific Aortic Stenosis (2012) (16)
Chelation therapy after the Trial to Assess Chelation Therapy: results of a unique trial (2014) (16)
Periodic acceleration (pGz) CPR in a swine model of asphyxia induced cardiac arrest. Short-term hemodynamic comparisons. (2008) (16)
Treatment and prevention of atrial fibrillation with non-antiarrhythmic pharmacologic therapy. (2005) (16)
Low-Level Cadmium Exposure and Atherosclerosis (2021) (16)
Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years. (2009) (15)
Brain natriuretic peptide and HIV-related cardiomyopathy. (2002) (15)
Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy (2016) (14)
Adverse Effects of First‐Degree AV‐Block in Patients with Sinus Node Dysfunction: Data from the Mode Selection Trial (2013) (13)
Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study. (2008) (13)
The effects of prostaglandin inhibition on whole-body ischemia-reperfusion in swine. (2008) (13)
Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT). (2009) (12)
Right anterior minithoracotomy versus median sternotomy surgery for native mitral valve infective endocarditis. (2014) (12)
The Effects of Equitation (Horseback Riding) on a Motion Responsive DDDR Pacemaker (1990) (12)
Comparison of stress cardiomyopathy in Hispanic and non-Hispanic patients. (2013) (12)
Effect of Spinal Manipulation of Upper Cervical Vertebrae on Blood Pressure: Results of a Pilot Sham-Controlled Trial. (2016) (12)
Enhanced vasculotoxic metal excretion in post‐myocardial infarction patients following a single edetate disodium‐based infusion (2017) (12)
Pacemakers and defibrillators: recent and ongoing studies that impact the elderly. (2006) (12)
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST). (2009) (11)
Acute Effects of “Delayed Postconditioning” With Periodic Acceleration After Asphyxia Induced Shock in Pigs (2008) (11)
Documented Symptomatic Bradycardia and Symptom Relief in Patients Receiving Permanent Pacemakers: An Evaluation of the Joint ACC/AHA Pacing Guidelines (1988) (11)
Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT]). (2010) (11)
Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT]). (2013) (11)
Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes. (2019) (10)
Aspirin, postmenopausal hormones, and C-reactive protein. (2002) (10)
Review Article: Examining Treatment of ST-Elevation Myocardial Infarction: The Importance of Early Intervention (2010) (10)
Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT). (2013) (10)
Reduction in ventricular pacing and its long-term clinical outcomes: Preliminary results of the SAVE PACe trial (2005) (10)
Selective activation of neurohormonal systems in post-infarction left ventricular dysfunction (1991) (9)
Myocardial Perfusion Grade After Late Infarct Artery Recanalization Is Associated With Global and Regional Left Ventricular Function at One Year: Analysis From the Total Occlusion Study of Canada-2 (2010) (9)
Quality-of-Life Outcomes With a Disodium EDTA Chelation Regimen for Coronary Disease: Results From the Trial to Assess Chelation Therapy Randomized Trial (2014) (9)
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT). (2009) (9)
Left ventricular dilatation following myocardial infarction: clinical course and potential for therapy. (1989) (9)
Interventional Cardiology Long-Term Effects of Percutaneous Coronary Intervention of the Totally Occluded Infarct-Related Artery in the Subacute Phase After Myocardial Infarction (2011) (8)
The association of the heart failure score with mortality and heart failure hospitalizations in elderly patients: insights from the Mode Selection Trial (MOST). (2006) (8)
Chelation therapy to prevent diabetes-associated cardiovascular events (2018) (8)
The Use of Nitrates in the Prevention of Contrast-Induced Nephropathy in Patients Hospitalized After Undergoing Percutaneous Coronary Intervention (2014) (8)
Pacemaker‐Mediated Tachycardia Initiated by Coincident P‐Wave Undersensing and Ventricular Blanking Period (1985) (8)
Have the Results of Randomized Clinical Trials of Pacing Altered the Practice of Cardiac Pacing? (2003) (8)
Comparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome. (1993) (7)
Limb Preservation Using Edetate Disodium-based Chelation in Patients with Diabetes and Critical Limb Ischemia: An Open-label Pilot Study (2019) (7)
AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction (2004) (7)
Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT). (2012) (7)
Non-selective cyclooxygenase inhibition before periodic acceleration (pGz) cardiopulmonary resuscitation (CPR) in a porcine model of ventricular fibrillation. (2008) (7)
Urinary Metal Levels after Repeated Edetate Disodium Infusions: Preliminary Findings (2020) (6)
Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider? (2016) (6)
Chelation Therapy: A New Look at an Old Treatment for Heart Disease, Particularly in Diabetics (2015) (6)
Plasma Levels of Brain Natriuretic Peptide: A Potential Marker for HIV-Related Cardiomyopathy (2002) (6)
The Effect of Posture on the Response to Atrioventricular Synchronous Pacing in Patients with Underlying Cardiovascular Disease (1991) (6)
Significance of a lateral Q wave following first anterior wall acute myocardial infarction. (1990) (6)
Physical working capacity after acute myocardial infarction in patients with low ejection fraction and effect of captopril. (1995) (6)
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT). (2012) (6)
The predictive value of LV systolic sphericity index, a magnification-independent assessment of LV shape (1996) (5)
Left ventricular remodeling: clinical significance and therapy (1997) (5)
Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial. (2009) (5)
Distribution and determinants of myocardial perfusion grade following late mechanical recanalization of occluded infarct‐related arteries postmyocardial infarction: A report from the occluded artery trial (2008) (5)
Dual-chamber vs ventricular pacing in the elderly: quality of life and clinical outcomes. (1999) (5)
Thiazolidinediones Could Improve Endothelial Dysfunction and Risk of Premature Coronary Heart Disease in HIV-Infected Patients (2002) (5)
ENHANCED VASCULOTOXIC METAL EXCRETION IN POST-MYOCARDIAL INFARCTION PATIENTS RECEIVING EDETATE DISODIUM-BASED INFUSION (2016) (5)
An update on clinical trials in pacing: is dual chamber pacing better? (2004) (5)
Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2. (2016) (5)
Edetate Disodium–Based Treatment in a Patient With Diabetes and Critical Limb Ischemia After Unsuccessful Peripheral Arterial Revascularizations: A Case Report (2019) (5)
Low-level metal contamination and chelation in cardiovascular disease - a ripe area for toxicology research. (2021) (5)
Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review (2021) (4)
Where does the Occluded Artery Trial leave the late open artery hypothesis? (2007) (4)
Postmyocardial infarction patients: experience from the SAVE trial. (1995) (4)
Treatment of Patients with Prior Exit Block Using a Novel Steroid‐Eluting Active Fixation Lead (1994) (4)
Paradoxical elevation of threshold to angina pectoris by cold pressor test in men with significant coronary artery disease. (1989) (4)
Cardiac pacing for bradycardia support: Evidence-based approach to pacemaker selection and programming (2004) (4)
Chelation therapy and cardiovascular outcomes--in reply. (2013) (4)
Exercise capacity and N-terminal pro-brain natriuretic peptide levels with biventricular vs. right ventricular pacing for atrioventricular block: results from the PREVENT-HF German Substudy. (2014) (4)
Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients (2016) (3)
A meta-analysis that misses the mark. (2008) (3)
Effect of high‐dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT) (2018) (3)
Left ventricular hypertrophy in post-myocardial infarction left ventricular remodelling and in hypertension; similarities and contrasts. (1993) (3)
Abstract 2811: Predictors of Outcome and the Lack of Effect of PCI Across the Risk Strata in Patients With Persistent Total Occlusion After Myocardial Infarction: Results from the Occluded Artery Trial (OAT) (2007) (3)
Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT). (2012) (3)
Update in internal medicine. (2000) (3)
Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT). (2011) (3)
The Trial to Assess Chelation Therapy 2 (TACT2): Rationale and Design. (2022) (3)
Edetate Disodium-based Treatment in a Woman with Diabetes and Critical Limb Ischemia Scheduled for Lower Extremity Amputation (2019) (3)
[Interpretation of negative clinical trials]. (1998) (3)
Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial). (2012) (2)
A comparison of clinical events in a randomized clinical trial of DDDR versus DDD pacing (2005) (2)
Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction. (2014) (2)
Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarction. (2010) (2)
VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers (2020) (2)
6-YEAR OUTCOMES OF PATIENTS TREATED WITH DES, BMS OR MEDICAL THERAPY IN THE OAT TRIAL (2011) (2)
Response to Fang Fang, MB, PhD, John E. Sanderson, MD, Cheuk-man Yu, MD. (2015) (2)
Effect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment. (2012) (2)
Patients With ST-Elevation Myocardial Infarction : 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of (2012) (2)
Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT). (2020) (2)
Routine use of biventricular pacing is not warranted for patients with heart block. (2015) (2)
923-7 Infarct Artery Patency does not Prevent LV Remodeling (1995) (2)
DIFFERENTIAL OUTCOMES WITH CHELATION THERAPY AMONG PATIENTS WITH ANTERIOR VERSUS NON-ANTERIOR MYOCARDIAL INFARCTION: A TACT SUBSTUDY (2014) (2)
Electrocardiogram by Einthoven 63 years earlier. (1984) (2)
The clinical significance of left ventricular sphericity in patients undergoing mitral valve surgery (1998) (1)
Abstract 11546: Clinical Benefit of EDTA Chelation Therapy in Patients With Diabetes in the Trial to Assess Chelation Therapy (TACT) (2013) (1)
Should ACE inhibitors be administered to all patients with acute myocardial infarction? (1995) (1)
Abstract 10466: Post-myocardial Infarction Treatment With Edetate Disodium was Safe in the Trial to Assess Chelation Therapy (2015) (1)
Editorial: Who Needs a New Journal? (1997) (1)
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization (2023) (1)
Abstract 5580: Sex Differences in Outcomes after Myocardial Infarction with Persistent Total Occlusion of the Infarct Artery: Analysis of the Occluded Artery Trial (2008) (1)
Treatment crossovers did not affect randomized treatment comparisons in the Mode Selection Trial (MOST). (2006) (1)
Differential outcomes with edetate disodium-based treatment among stable post anterior vs. non-anterior myocardial infarction patients. (2020) (1)
The Beneficial Effect of a High-Fat, High-Protein, Low-Carbohydrate Diet on Body Weight and HDL Cholesterol (1998) (1)
Abstract 11054: Clinical Benefit of EDTA-based Chelation Therapy and High-dose Oral Multivitamins and Multiminerals in TACT- An Expanded Comparison of 2 Factorial Groups (2013) (1)
Abstract 1934: PCI Failure in the Occluded Artery Trial (OAT): Frequency, Mechanisms, and Outcome (2007) (1)
Impact of Stress Testing Prior to PCI or Medical Management on Outcomes of Patients With Persistent Total Occlusion After Myocardial Infarction : Analysis From the Occluded Artery Trial (2009) (1)
Abstract 18819: Graded Benefit of EDTA Chelation in Post-MI Patients with Diabetes Treated with Different Hypoglycemic Strategies (2014) (1)
Abstract 13116: Persistent Lack of Benefit of Late Revascularization of the Occluded Coronary Artery Post-MI - The Occluded Artery Trial (OAT) Long Term Results (2010) (1)
Abstract 2812: Predictors of Reinfarction Following PCI or Medical Management in Patients With Persistent Total Occlusion After Myocardial Infarction: Results from the Occluded Artery Trial (OAT) (2007) (1)
Abstract 10476: Effect of High-dose Oral Multi-vitamins and Minerals in Patients Not Treated With Statins in the Trial to Assess Chelation Therapy (2015) (1)
Clinical Trials in Cardiac Pacing: Justification, Design, and Preliminary Results of the United States Trials (1998) (1)
Long-term outcome of abdominal aortic aneurysm repair via a retroperitoneal approach. (2016) (1)
1167-220 Pacing mode and quality of life in the mode selection trial (2004) (0)
Potential Role of Edetate Disodium-Based Therapy in the Treatment of Atherosclerosis in Patients with Diabetes (2019) (0)
Combined phosphodiesterase inhibitors in end-stage heart failure: A case presentation (2013) (0)
Should chelation therapy be abandoned (2013) (0)
Abstract 2986: Did Early Hazard of PCI Offset Late Benefit in the Occluded Artery Trial (OAT)? (2007) (0)
Abstract P15: Periodic Acceleration (pGz) Preconditioning in Swine Increases Endothelial Derived NO and Phosphorylated eNOS via Akt Pathway (2008) (0)
EFFECT OF CHELATION THERAPY ON CARDIOVASCULAR EVENTS BY CHRONIC KIDNEY DISEASE STAGE: DATA FROM THE TRIAL TO ASSESS CHELATION THERAPY (TACT) (2014) (0)
Abstract 13005: Pilot Study of Edetate Disodium-Based Chelation in Diabetics With Critical Limb Ischemia (2018) (0)
Changes in local curvature accompany left ventricular enlargement following anterior myocardial infarction (1990) (0)
myocardial infarction Right ventricular dysfunction and risk of heart failure and mortality after (2011) (0)
Response to, "Atrial fibrillation and quality of life" (2009) (0)
Abstract 2393: Similar Long-Term Outcomes After PCI Success, PCI Failure, and no PCI in the Occluded Artery Trial (OAT) (2007) (0)
Abstract P170: The Association of Urinary Cadmium and Zinc With Lower Extremity Amputations. Evidence From the Strong Heart Study (2023) (0)
Late Intervention on an Occluded Infarct-Related Artery: A Meta-analysis of the Randomized Controlled Trials (2007) (0)
Effects of aortic valve replacement on the severity of mitral regurgitation (1996) (0)
Assessment of Chelation Therapy: The TACT Trial (2012) (0)
Institutional report - Cardiac general The obesity paradox in elderly obese patients undergoing coronary artery bypass surgery (2011) (0)
Incidence, mechanisms and duration of inappropriate mode switching in ADEPT (advanced elements of pacing trial) (2005) (0)
To the Editor (1989) (0)
Abstract P452: Urinary Metal Levels After Repeated Chelation With Edetate Disodium: Additional Evidence in Support of Metals as Cardiovascular Risk Factors (2020) (0)
Abstract 45: Non-Selective Cyclooxygenase Inhibition Prior To Periodic Acceleration (pGz) Cardiopulmonary Resuscitation (CPR) in a Porcine Model of Ventricular Fibrillation (2006) (0)
Reply to letter to the editor by Edzard Ernst (2012) (0)
A Simple Electrocardiographic Predictor of Early Recovery of Left Ventricular Function in Stress Cardiomyopathy (2012) (0)
MY APPROACH to the use of chelation therapy. (2016) (0)
Evidence-based medicine. (1999) (0)
p-Wave Duration and Dispersion and Ascertaining the Optimal Site for Atrial Pacing (2013) (0)
Antiarrhythmic drug use and mortality in pacemaker patients with sinus node dysfunction (2005) (0)
Low Rate of Heart Failure Hospitalization after Myocardial Infarction in the Occluded Artery Trial (OAT) (2010) (0)
[Ventricular geometry and heart failure]. (1999) (0)
Effects of captopril on mortality and morbidity rates in patients with left ventricular dysfunction following myocardial infarction: Results of survival and ventricular hypertrophic studies (1993) (0)
International Assessment of Atrial Fibrillation in Myocardial Infarction: The VALIANT Registry (2003) (0)
LETTERS TO THE EDITOR (1999) (0)
Exploring non-conventional risk factors in patients with polyvascular disease. (2021) (0)
Clinical significance of chronotropic incompetence in 872 ADEPT patients (2005) (0)
Abstract 1748: Clinical and Coronary Angiographic Correlates of Myocardial Perfusion Grade Following Late Mechanical Reperfusion of Occluded Infarct-related Arteries Post-Myocardial Infarction - a Total Occlusion Study of Canada-2 Substudy (2006) (0)
The TACT Trial: Provocative Results for High-Dose Vitamins and Chelation Therapy (2013) (0)
Abstract 16630: Clinical Benefit of Chelation Therapy in Post-MI Patients With Diabetes and Peripheral Artery Disease (2014) (0)
Angiotensin Converting Enzyme Inhibitors After and During Acute Coronary Syndromes, and, in Particular, Myocardial Infarction (2003) (0)
[Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment]. (2022) (0)
A SIMPLE RISK PREDICTION SCORE FOR PATIENTS UNDERGOING MINIMALLY INVASIVE VALVE SURGERY (2013) (0)
lcohol Consumption and Prognosis n Patients With Left Ventricular Systolic ysfunction After a Myocardial Infarction (2016) (0)
Outcome of cardiopulmonary resuscitation after in-hospital cardiac arrest in octogenarians (1998) (0)
Predictors of quality of life in 872 paced patients with chronotropic incompetence in the ADEPT study (2005) (0)
Circadian and Seasonal Distribution of Stress Cardiomyopathy in Hispanic and non-Hispanic Patients (2017) (0)
CHA2DS2VASC SCORE IS SUPERIOR TO ATRIAL FIBRILLATION IN PREDICTING POST-OPERATIVE ISCHEMIC STROKE IN PATIENTS UNDERGOING CARDIOTHORACIC SURGERY (2014) (0)
1142-177 Antecedent hypertension and the risk of subsequent left ventricular remodelling after acute myocardial infarction: Insights from the survival and ventricular enlargement trial (2004) (0)
The association of the heart failure score with mortality and hospitalizations in pacemaker patients (2003) (0)
URINARY LEAD EXCRETION CORRELATES WITH OVERALL TOXIC METAL EXCRETION IN PATIENTS WITH CORONARY ARTERY DISEASE: A SENTINEL BIOMARKER? (2017) (0)
Abstract 83: Preconditioning With Periodic Acceleration (pGz) Prior To Whole Body Ischemia Reperfusion Injury Ameliorates Myocardial Stunning And Arrhythmias (2007) (0)
International patterns in the care of acute myocardial infarction patients in the occluded artery trial (OAT): Characteristics of 1,835 screened patients (2003) (0)
549 Pulse pressure and the risk of heart failure hospitalization after acute myocardial infarction: insights from the SAVE trial (2008) (0)
WIRKUNG VON CAPTOPRIL AUF MORTALITAT UND MORBIDITAT BEI PATIENTEN MIT LINKSVENTRIKULARER DYSFUNKTION NACH MYOKARDINFARKT. ERGEBNISSE DER 'SURVIVAL-AND-VENTRICULAR-ENLARGEMENT'-STUDIE (1992) (0)
Trial to Assess Chelation Therapy (TACT) provides scant evidence for benefits of chelation therapy in cardiovascular disease (2014) (0)
Angiotensin-Converting Enzyme Inhibitors in Acute Coronary Syndromes (1999) (0)
Abstract 10999: CHADS2 and CHA2DS2-VASc scores are Predictive of Adverse Cardiovascular Outcomes in All Patients, Not Just Those With a Diagnosis of AF: an Analysis of the 2010 Patients From the MOST Trial (2013) (0)
Abstract 2465: Association of Myocardial Perfusion Grade After Late Infarct Reperfusion with Baseline Indices of Global LV Function; Analysis from the Total Occlusion Study of Canada-2 (2006) (0)
AN UPSIDE DOWN PERSPECTIVE: YOGA INVERSIONS IN A PATIENT WITH ASCENDING AORTIC ANEURYSM (2017) (0)
The Heart Failure Home Care (HFHC) Trial : A Multicenter, Randomized, Controlled Trial of a Computer Based Telephonic Heart Failure Monitoring System: Design and Methods (2003) (0)
Baseline Characteristics of the Patients in the Two Treatment Groups * Placebo (2005) (0)
1023-89 Chelation therapy for patients with coronary heart disease: Findings from the pilot to assess chelation therapy (2004) (0)
Chronic kidney disease, ejection fraction and heart failure in patients with occluded infarct-related arteries post-myocardial infarction: Data from the occluded artery trial (2006) (0)
Post myocardial infarction (MI) management patterns of pattents in the survival and ventricular enlargement (SAVE) study at Canadian and US Centers (1990) (0)
Abstract 2031: Late Clinical Outcomes of Diabetic Patients Randomized in the Occluded Artery Trial (OAT) (2008) (0)
Abstract 102: Differential Effects of NOS Inhibition on CPR Outcomes in Pigs (2006) (0)
Low-Level Cadmium Exposure and Atherosclerosis (2021) (0)
LONG-TERM OUTCOMES OF A HYBRID APPROACH OF PERCUTANEOUS CORONARY INTERVENTION FOLLOWED BY MINIMALLY INVASIVE VALVE SURGERY (2014) (0)
Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment. (2022) (0)
RESPONSE to Letter to the Editor by Yen. (2022) (0)
Abstract 2813: Causes of Death in Early MI Survivors With Persistent Vessel Occlusion: Results from the Occluded Artery Trial (OAT) (2007) (0)
Correlation of Within-Plaque Inflammatory Biomarkers with Coronary Plaque Subtypes Categorized by Contrast-Enhanced Coronary Computerized Tomography (2013) (0)
Abstract 2633: Post Treatment with Periodic Acceleration (pGz) after Cardiac Arrest Decreases Acute Post Resuscitation Myocardial Stunning in Swine (2007) (0)
Abstract 16911: Behind the Looking Glass: Comparing Time to First Event versus Multiple Events Analyses in a Post-myocardial Infarction Clinical Trial (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gervasio A. Lamas?

Gervasio A. Lamas is affiliated with the following schools:

Gervasio A. Lamas's Academic­Influence.com Rankings

Why Is Gervasio A. Lamas Influential?

Gervasio A. Lamas's Published Works

Published Works

What Schools Are Affiliated With Gervasio A. Lamas?

Gervasio A. Lamas's AcademicInfluence.com Rankings